- Home
- APLE vs MLTX Comparison
APLE vs MLTX Comparison
Compare APLE & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLE
- MLTX
- Stock Information
- Founded
- APLE 2007
- MLTX 2021
- Country
- APLE United States
- MLTX Switzerland
- Employees
- APLE N/A
- MLTX N/A
- Industry
- APLE Real Estate Investment Trusts
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- APLE Real Estate
- MLTX Health Care
- Exchange
- APLE Nasdaq
- MLTX Nasdaq
- Market Cap
- APLE 2.8B
- MLTX 2.8B
- IPO Year
- APLE 2015
- MLTX N/A
- Fundamental
- Price
- APLE $12.52
- MLTX $49.00
- Analyst Decision
- APLE Buy
- MLTX Strong Buy
- Analyst Count
- APLE 4
- MLTX 7
- Target Price
- APLE $15.75
- MLTX $73.33
- AVG Volume (30 Days)
- APLE 3.4M
- MLTX 463.2K
- Earning Date
- APLE 08-06-2025
- MLTX 08-06-2025
- Dividend Yield
- APLE 7.67%
- MLTX N/A
- EPS Growth
- APLE N/A
- MLTX N/A
- EPS
- APLE 0.79
- MLTX N/A
- Revenue
- APLE $1,429,658,000.00
- MLTX N/A
- Revenue This Year
- APLE $1.43
- MLTX $103.42
- Revenue Next Year
- APLE $2.13
- MLTX N/A
- P/E Ratio
- APLE $15.74
- MLTX N/A
- Revenue Growth
- APLE 4.98
- MLTX N/A
- 52 Week Low
- APLE $10.44
- MLTX $31.42
- 52 Week High
- APLE $16.50
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- APLE 64.39
- MLTX 63.01
- Support Level
- APLE $11.78
- MLTX $46.37
- Resistance Level
- APLE $12.65
- MLTX $49.29
- Average True Range (ATR)
- APLE 0.28
- MLTX 1.85
- MACD
- APLE 0.09
- MLTX 0.05
- Stochastic Oscillator
- APLE 86.67
- MLTX 88.30
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.